POINT BIOPHARMA GLOBAL INC. Retained Earnings
POINT BIOPHARMA GLOBAL INC. had Retained Earnings of -$27.71 million as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2023-11-13
- 2023-09-30: Retained Earnings (Accumulated Deficit) -$27.71M.
- 2023-06-30: Retained Earnings (Accumulated Deficit) -$2.93M.
- 2023-03-31: Retained Earnings (Accumulated Deficit) $22.48M.
- 2022-12-31: Retained Earnings (Accumulated Deficit) $39.01M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2023-09-30 | -$27.71M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | -$2.93M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $22.48M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $39.01M 10-Q · filed 2023-11-13 | |
| 2022-09-30 | -$124.26M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$100.25M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | -$75.67M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | -$59.28M 10-K · filed 2023-03-27 | |
| 2021-09-30 | -$45.09M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | -$27.97M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | -$1.71M 10-Q · filed 2021-04-29 | |
| 2020-12-31 | -$13.38M 10-K · filed 2022-03-25 | -$311.51K 10-K · filed 2021-03-04 |
| 2020-09-30 | -$184.71K 10-Q · filed 2020-11-02 | |
| 2020-06-30 | -$19.37K 10-Q · filed 2020-08-20 |